hodgkin disease

Showing NaN - NaN of 8

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hodgkin Disease, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell Trial in Worldwide (pembrolizumab, Favezelimab)

Recruiting
  • Hodgkin Disease
  • +2 more
  • pembrolizumab
  • Favezelimab
  • Gilbert, Arizona
  • +24 more
Aug 18, 2022

Hodgkin Disease Trial in Worldwide (Nivolumab, brentuximab vedotin, bendamustine)

Active, not recruiting
  • Hodgkin Disease
  • Nivolumab
  • +2 more
  • Birmingham, Alabama
  • +77 more
Jul 21, 2022

Hodgkin Disease Trial in Worldwide (Nivolumab, Doxorubicin, Vinblastine)

Active, not recruiting
  • Hodgkin Disease
  • Los Angeles, California
  • +37 more
Oct 25, 2021

Hodgkin Disease Trial in United States (brentuximab vedotin, bendamustine)

Completed
  • Hodgkin Disease
  • Birmingham, Alabama
  • +12 more
Jan 24, 2019

Non Hodgkin's Lymphoma, Hodgkin Disease, Multiple Myeloma Trial in Boston (Fludarabine and total body irradiation, Total body

Terminated
  • Non Hodgkin's Lymphoma
  • +2 more
  • Fludarabine and total body irradiation
  • Total body irradiation
  • Boston, Massachusetts
    Massachusetts General Hospital
Mar 26, 2018

Chronic Kidney Disease, Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL) Trial in Boston (Haploidentical Bone

Unknown status
  • Chronic Kidney Disease
  • +16 more
  • Haploidentical Bone Marrow/Kidney
  • Boston, Massachusetts
    Massachusetts General Hospital
Mar 21, 2017

Leukemia, Myeloid, Chronic, Anemia, Aplastic, Myelofibrosis Trial in Gainesville, Boston (Parathyroid Hormone (teriparatide))

Terminated
  • Leukemia, Myeloid, Chronic
  • +7 more
  • Parathyroid Hormone (teriparatide)
  • Gainesville, Florida
  • +3 more
Apr 22, 2013

Hodgkin Disease, Lymphoma, Large-Cell, Sarcoma, Kaposi Trial in United States (SGN-30 (mAb))

Completed
  • Hodgkin Disease
  • +4 more
  • SGN-30 (monoclonal antibody)
  • Birmingham, Alabama
  • +9 more
Oct 7, 2011